Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

120.48 +1.22 (+1.03%)

Streaming Delayed Price Updated: 10:25 AM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

35 36 Next >

Bionano Stock Looks to Have a Monster Comeback in Its Future ↗

February 17, 2022

Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.

Via InvestorPlace

African Coronavirus Surveillance Network Provides Early Warning for World

February 17, 2022

SOURCE: Illumina

Via 3BL Media

Give peace a chance ↗

February 15, 2022

Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.

Via Talk Markets

From Patents to Patients: Meet the Women Making a Difference at Illumina

February 15, 2022

SOURCE: Illumina

Via 3BL Media

Topics Intellectual Property

Illumina to Support Neuro Genomics Project at McGill University

February 14, 2022

SOURCE: Illumina

Via 3BL Media

Illumina's Q4 Profit Falls Despite Topline Growth Of 26% ↗

February 11, 2022

Illumina Inc (NASDAQ: ILMN) reported

Via Benzinga

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

Barron's Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More ↗

February 12, 2022

This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to...

Via Benzinga

Dominion Energy, Under Armour, And Expedia Among Another Slew Of Earnings Reports ↗

February 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index...

Via Benzinga

Expert Ratings For Illumina ↗

February 11, 2022

Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗

February 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

February 11, 2022

SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading.

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Following Thursday's Plunge ↗

February 11, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch For February 11, 2022 ↗

February 11, 2022

Some of the stocks that may grab investor focus today are:

Via Benzinga

Illumina: Q4 Earnings Insights ↗

February 10, 2022

Illumina (NASDAQ:ILMN) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Illumina beat estimated earnings...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Illuminating Rare Disease: Get to Know SLC6A1 Connect

February 08, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer

February 07, 2022

SOURCE: Illumina

Via 3BL Media

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

How Far Can the Stock Market Fall? ↗

February 05, 2022

The stock market as measured by the S&P 500 has been correcting since the start of the new year. Most of the damage has come from the significantly overvalued constituents.

Via Talk Markets

Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia

February 04, 2022

SOURCE: Illumina

Via 3BL Media

Illumina Earns Gold Class in the S&P Global's 2022 Sustainability Yearbook

February 03, 2022

SOURCE: Illumina

Via 3BL Media

Topics Stocks

Promising Results Continue to Develop Optimism in Fight Against Cancers

January 27, 2022

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group – There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types...

Via FinancialNewsMedia

Illumina's Diversity, Equity, and Inclusion Actions Earn External Recognition and Further Advance Our Culture of Care

January 27, 2022

SOURCE: Illumina

Via 3BL Media

Panic reversal ↗

January 26, 2022

Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise.

Via Talk Markets

Stocks That Hit 52-Week Lows On Wednesday ↗

January 26, 2022

During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company...

Via Benzinga

Illumina Grant Recipient Addresses Food Insecurities Through the Breeding of Yams

January 26, 2022

SOURCE: Illumina

Via 3BL Media

Multiplex Assays Market worth $4.3 billion by 2026 – Key Players are Illumina, Inc. (US), Luminex Corporation (US)

January 24, 2022

Via AB Newswire

Buy Smart With Software Stocks on the Dip ↗

January 24, 2022

With tech taking over, software stocks are inevitable winners. But when buying the dip, look for low valuation and high durability.

Via InvestorPlace

Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development

January 20, 2022

SOURCE: Illumina

Via 3BL Media

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.